Method of treating compulsive disorders with alpha-2B adrenergic receptor agonists

Details for Australian Patent Application No. 2010289703 (hide)

Owner Allergan, Inc.

Inventors Gil, Daniel W.; Donello, John E.; Luhrs, Lauren M. B.

Agent Davies Collison Cave

Pub. Number AU-A-2010289703

PCT Pub. Number WO2011/028621

Priority 61/237,165 26.08.09 US

Filing date 26 August 2010

Wipo publication date 10 March 2011

International Classifications

A61K 31/47 (2006.01) - Quinolines

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/028621 Priority application(s): WO2011/028621

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010289706-Patient-specific orthopedic implants and models

2010289692-MRI and optical assays for proteases